Skip to content

Clinical trials

Observational Carcinoma, Lobular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Lobular Phase: Observational Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20082
20093
20182
20221
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Unknown status4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology2
Memorial Sloan Kettering Cancer Center2
City of Hope Medical Center1
Dana-Farber Cancer Institute1
Duke University1
Hellenic Cooperative Oncology Group1
Istituto Oncologico Veneto IRCCS1
Julia Foldi1
Methodist Health System1
NSABP Foundation Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Lobular18
Breast Neoplasms10
Breast Carcinoma In Situ5
Carcinoma, Ductal, Breast5
Carcinoma, Intraductal, Noninfiltrating5
Lung Neoplasms2
Barrett Esophagus1
Brain Neoplasms1
Breast Neoplasms, Male1
Carcinoma in Situ1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.